These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14224677)

  • 1. [ACTION OF ORAL HEPARINOIDS ON METABOLISM OF LIPIDS].
    BOSTANCI N; BASAR M
    Turk Tip Cemiy Mecm; 1964 Sep; 30():564-70. PubMed ID: 14224677
    [No Abstract]   [Full Text] [Related]  

  • 2. [The blood, hepatic and aortic lipids in chronic experimental carbon disulfide poisoning in rabbits. Action of duodenal heparinoid extract].
    NICROSINI F; PASOTTI C; DEL FAVERO A; RICOTTI V; MARCHESI E
    Arch Sci Med (Torino); 1963 Feb; 115():109-28. PubMed ID: 13938462
    [No Abstract]   [Full Text] [Related]  

  • 3. [Survey of lipid metabolism in 100 patients suspected of atherosclerosis. Therapeutic trial of a new synthetic heparinoid: CB 8061. (Apropos of 30 cases)].
    LEBLOIS J; LESAGE R; RIVET E
    Lille Med; 1962 Mar; 7():256-63. PubMed ID: 14463327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of an extractive heparinoid on electrocardiographic changes induced with an oral lipid overload].
    Ferlito S; Bonaventura S; Fichera C
    Minerva Cardioangiol; 1973 Dec; 21(12):821-6. PubMed ID: 4130995
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protective action of duodenal heparinoid in experimental carbon tetrachloride poisoning in rabbits].
    PICCINELLI O; NICROSINI F; DEL FAVERO A; PASOTTI C; RICOTTI V
    Arch Sci Med (Torino); 1963 Feb; 115():129-46. PubMed ID: 13943249
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the clearing action of a heparinoid obtained from duodenal mucosa].
    HAMMERL H; PICHLER O
    Clin Ter; 1963 May; 25():250-7. PubMed ID: 13952389
    [No Abstract]   [Full Text] [Related]  

  • 7. [ACTION OF A DUODENAL HEPARINOID ON PLASMA LIPIDS AND SUGARS].
    BERRETA JA; CAMPAGNOLI M; SALITA S; LOFFLER AJ; ZUNDER J; PRESS L; BARBEITOARANDA A; KALINOV A
    Prensa Med Argent; 1964 Nov; 51():1267-71. PubMed ID: 14240198
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modifications of the total blood lipids and of various lipid fractions induced by a heparinoid extract of the duodenal mucosa].
    NICROSINI F; PICCINELLI O
    G Clin Med; 1959 Aug; 40():1271-88. PubMed ID: 14427029
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTION OF THE HEPARINOID, CB-8061, IN MAN. I. APPEARANCE OF PLASMA CLEARING CAPACITY AFTER INJECTION OF A SINGLE DOSE OF THE PRODUCT].
    DUREUX JB; BRIGNON JJ; MARCHAL C
    Therapie; 1964; 19():879-89. PubMed ID: 14190943
    [No Abstract]   [Full Text] [Related]  

  • 10. [ACTION OF A SYNTHETIC HEPARINOID ON THE HUMORAL SYNDROME OF ATHEROSCLEROSIS].
    RAYNAUD R; BROCHIER ; TADEI
    Rev Atheroscler; 1963; 5():23-31. PubMed ID: 14121729
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus].
    Markoski S
    Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACTION OF A HEPARINOID IN ARTERIOSCLEROTICS UNDER ANTICOAGULANT THROMBOLYTIC TREATMENT].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1879-84. PubMed ID: 14168961
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE SERUM LIPOPROTEINS].
    BLATRIX C; CHARONNAT S
    Presse Med (1893); 1964 Jun; 72():1719-23 CONCL. PubMed ID: 14154050
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDIES ON THE CLEARANCE INDUCING EFFECTS OF A NATURAL HEPARINOID].
    WAGENER H; KRUSZEWSKA B; SCHULZ U
    Arzneimittelforschung; 1964 Aug; 14():879-83. PubMed ID: 14344130
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the effect of a heparinoid extracted from the duodenal mucosa on changes of serum lipoids after parenteral fat infusion].
    HAMMERL H; HENK W; HOLLER I; PICHLER O
    Wien Klin Wochenschr; 1963 Jan; 75():64-7. PubMed ID: 13952385
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACTION OF DUODENAL HEPARINOID ON GLUCIDE METABOLISM].
    BARBEITOARANDA A; PRESS L; GIORDANO J; LOPEZGIL AL; CAMPAGNOLI M
    Dia Med; 1963 Sep; 35():1491-3. PubMed ID: 14089621
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE USE OF HEPARINOID IN THE TREATMENT OF PATIENTS WITH CORONARY ATHEROSCLEROSIS].
    KOROCHKIN IM
    Klin Med (Mosk); 1963 Oct; 41():49-55. PubMed ID: 14140171
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged heparinoid treatment of coronary atherosclerosis patients].
    Korochkin IM
    Kardiologiia; 1968 Jan; 8(1):58-62. PubMed ID: 4172568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.